Skip to main content

Table 4 miRNA levels differing in patients with active CD and healthy controls. Bold type indicates the most significantly differed miRNAs

From: In search for interplay between stool microRNAs, microbiota and short chain fatty acids in Crohn’s disease - a preliminary study

Statistics

Counts

Probe Name

Control

Active CD

Padjust

P-value

t-statistic

FC

Upper 95% CI

Lower 95% CI

SD

mean

Upper 95% CI

Lower 95% CI

SD

Active

5.33E-03

8.51E-05

−5.40

−4.59

958.18

427.83

344.98

693.00

212.23

91.98

71.92

152.11

hsa-miR-379-5p

5.33E-03

9.26E-05

−6.34

−5.91

467.18

170.93

192.70

319.05

57.79

32.79

14.95

45.29

hsa-miR-577

2.06E-02

5.38E-04

−4.40

−5.83

3688.71

1227.90

1600.70

2458.30

638.45

156.17

288.44

397.31

hsa-miR-26b-5p

7.68E-02

2.67E-03

−3.98

−4.70

993.98

403.93

383.81

698.95

370.73

34.95

200.82

202.84

hsa-miR-642a-3p

1.79E-01

7.79E-03

3.07

3.11

19,580.00

N/A

13,149.21

9472.62

39,519.23

10,096.10

17,597.13

24,807.66

hsa-miR-1246

2.73E-01

1.47E-02

3.09

11.65

121.66

15.04

69.36

68.35

5015.90

N/A

3131.06

2398.27

hsa-miR-223-3p

2.73E-01

1.66E-02

−2.70

−2.63

443.50

166.13

180.42

304.81

168.83

53.07

69.23

110.95

hsa-miR-944

3.43E-01

2.39E-02

2.79

4.17

69.14

28.49

26.44

48.81

709.34

49.38

394.70

379.36

hsa-miR-142-3p

3.52E-01

3.15E-02

−2.40

−3.15

957.20

182.63

503.83

569.91

431.54

1.03

257.47

216.28

hsa-miR-361-5p

3.52E-01

3.35E-02

2.34

2.49

351.20

77.52

178.02

214.36

760.10

189.66

341.16

474.88

hsa-miR-4516

3.52E-01

3.36E-02

2.57

3.00

63.15

30.85

21.01

47.00

496.06

N/A

301.27

244.19

hsa-miR-23a-3p

4.34E-01

4.92E-02

−2.32

−1.62

119.32

36.74

53.72

78.03

40.00

40.00

0.00

40.00

hsa-miR-378b